Skip to main content
Download PDF

Prevalence of anxiety symptoms in infertile men: a systematic review and meta-analysis

BMC Public Health volume 24, Article number: 1805 (2024) Cite this article

Abstract

Background

Infertility in men causes problems in various aspects of their lives, including personal, family and social life. One of the most important of these problems is anxiety. Anxiety in infertile men can affect their health, quality of life, and response to treatment, highlighting the significance of anxiety in these men. Thus, this systematic review and meta-analysis was conducted to investigate the prevalence of anxiety symptoms in infertile men.

Methods

To conduct this review study, two researchers independently searched international databases such as PubMed, Cochrane Library, Web of sciences, Scopus, PsyINFO, and the Google scholar search engine in English without considering any time limit until January 2, 2024. Keywords such as "anxiety," "infertility," "prevalence," and "epidemiology" were used, taking into account the specific search method of each database. Using the Newcastle–Ottawa Scale (NOS), the quality of the articles was evaluated by two researchers independently.

Results

In the systematic part of the study, 27 studies were included, and given the variety of measurement tools (8 different tools) used to investigate anxiety symptoms in infertile men, 24 studies were analyzed in five subgroups of tools. The pooled prevalence of anxiety symptoms in infertile men was 21.37% (95% CI: 15.73–27.02). The lowest and highest prevalence of anxiety in infertile men were related to the Beck anxiety inventory (BAI) and Depression Anxiety Stress Scales (DASS), accounting for 7.08% (95% CI: 3.27–10.90) and 34.90% (95%CI: 28.90–40.90) values respectively. This prevalence was 19.80% (95%CI: 9.01–30.59) for the Hospital Anxiety and Depression Scale (HADS), 30.06% (95%CI: 18.59–41.52) for the Spielberger Trait Anxiety Inventory (STAI-T), and 18.52% (95%CI: 7.76–29.29) for the Self-Rating Anxiety Scale (SAS).

Conclusion

The results of this systematic review and meta-analysis indicated that the prevalence of anxiety symptoms in infertile men requires special attention to healthcare planning. The healthcare system of different countries should evaluate the symptoms of anxiety in infertile men and take appropriate measures to reduce them according to the culture of the countries. It is recommended that all infertile couples be assessed for anxiety symptoms using a standardized tool during their initial evaluation.

Peer Review reports

Introduction

Defined as the inability to conceive after at least one year of unprotected intercourse, infertility is a complex issue [1]. According to the latest global statistics in 2023, the prevalence of infertility in the world has been reported to be approximately 17.5%. However, this rate has been reported to be between 4 and 39.7% in different areas of the world [2], and the male factor is the main or effective factor in 50% of couples [3].

Infertility, as one of the main reproductive health problems, is a serious issue for the World Health Organization (WHO), because the lack of attention to it in different countries has led to psychological problems at the individual and social levels [4]. Infertility often causes a variety of social, psychological, physical and financial stresses [5]. In examining the negative psychological, behavioral and social consequences of infertility for both couples, it has been found that infertile couples experience a wide range of negative emotions, including anxiety, fear, avoidance, depression, guilt, and frustration [6].

Anxiety is a natural adaptive response of the body to stressful events such as infertility. Anxiety is the most common mental health problem associated with infertility, and studies show that anxiety remains high throughout the infertility diagnosis and treatment cycle [7]. Infertile individuals are almost twice as likely as other people to suffer from anxiety [8]. The incidence of mental disorders in male and female infertility is 12.41% after 2 years of diagnosis, and infertile couples may require psychological support during the diagnosis and treatment of infertility [9].

Some studies have indicated that men have a more negative response to infertility than women [10]. Infertile men, like many infertile women, suffer from anxiety, isolation, self-blame, and feelings of sexual inadequacy [11]. Because of the connection between male fertility and sexual power, infertile men often feel that infertility leads to an incomplete identity and masculinity [12].

Moreover, the inability to have children causes psychological problems for infertile men, especially in societies where fertility is highly valued and fertility is one of the basic goals of marriage. Infertility can lead to fear of rejection, divorce, remarriage, and many unpleasant changes for infertile men and cause them anxiety [13]. Therefore, psychological assessment of infertile individuals may contribute to more efficient use of health services and reduce the negative effects of anxiety on fertility, thereby increasing the success of infertility treatment [14].

Based on reports from different parts of the world, the prevalence of anxiety in infertile men varies significantly. However, the prevalence of anxiety in infertile men has not been reported in any meta-analysis. One of the objectives of meta-analysis is to provide accurate and valid information from a large sample size by integrating studies. This process provides accurate data that can help clinicians and service providers design interventions and treatment strategies [15]. Therefore, this study examines the prevalence of anxiety in infertile men through a systematic review and meta-analysis with the aim of highlighting the significance of psychological evaluation as an essential component of the treatment process for infertile men.

Methods

Search Strategy

To conduct this systematic review, two researchers independently searched international databases such as PubMed, Cochrane Library, Web of sciences, Scopus, PsyINFO, and the Google scholar search engine in English without considering any time limit until January 2, 2024. Keywords such as "anxiety," "infertility," "prevalence," and "epidemiology" were used along with "AND" and "OR" operators, taking into account the specific search method of each database (Search Strategy Appendix 1). Our PROSPERO registration number is CRD42024497844.

Inclusion and exclusion criteria

Inclusion criteria were as follows: studies conducted on infertile men (defined as the absence of pregnancy after one year of sexual intercourse without the use of contraception), a minimum sample size of 30, reporting the prevalence of anxiety in infertile men using cross-sectional studies, using cross-sectional data from longitudinal studies, and investigating the prevalence of anxiety in infertile men using valid and standardized tools, such as reliable questionnaires or clinical interviews.

Exclusion criteria included the studies conducted on infertile men that did not report the prevalence of anxiety in infertile men, studies focusing on other mental and physical illnesses, history of psychiatric disorders means studies including participants with a history of psychiatric disorders, review articles, studies not written in English language, studies involving non-human samples, case reports, and studies for which the full text was not available.

Outcome measures

The main outcome of this study was the prevalence of anxiety symptoms in infertile men, investigated by standard tools such as clinical interview or valid and reliable questionnaires.

Data Extraction

The initial search for articles was conducted independently by two reviewers; the articles were entered into Endnote software, and duplicate articles were identified and removed. The titles, abstracts, and full texts of the articles were reviewed based on the inclusion criteria and then the articles were selected for data extraction. The data of the studies were extracted independently by two trained reviewers, and a third reviewer was consulted in case of disagreement.

Required information, including author name, year of publication, place of research, sample size, type of infertility, prevalence of anxiety in infertile men, mean age, duration of infertility and type of instrument, was extracted from the studies. The review steps are described in Fig. 1.

Fig. 1
figure 1

Flowchart for selection of studies

Full size image

Quality Evaluation

The Newcastle–Ottawa Scale (NOS) checklist for assessing the quality of non-randomized trials in meta-analyses, modified by Zhang et al., was used for quality evaluation [16]. This checklist consists of 5 sections covering sample representativeness, sample size, non-respondents, anxiety assessment, and quality of descriptive statistics reporting. Accordingly, the quality of articles that met the inclusion criteria was assessed and scored from 0 to 5 using the NOS, and based on total scores of less than 3, 3 and more, respectively, were classified into two high-risk and low-risk groups. The quality assessment in this study was performed independently by two reviewers (ZK and FM), and a third reviewer was consulted in case of disagreement between the researchers. The results of the quality assessment of the studies are available in Appendix 2. The coefficient of agreement between the researchers was K = 0.88. This systematic review was reported based on the preferred reporting items for systematic reviews and meta-analyses (PRISMA) [17].

Statistical analysis

In this review, the I2 index was used to assess heterogeneity among studies, and Egger's test was used to assess publication bias. In order to increase the validity of the study, at least 3 studies from each subgroup were used to the pooled prevalence. The subgroup analysis was performed based on tool type. Analysis was performed using IBM SPSS Statistics, version 29.0.1.0 (171). The significance level for statistical tests was set at 0.05.

Ethics approval and consent to participate

Ethical approval was obtained from the Ethics Committee, Faculty of Pharmacy, Nursing and Midwifery, Shahid Beheshti University (Ethical code: IR.SBMU.RETECH.REC.1402.497). All methods were performed in accordance with relevant guidelines and regulations.

Results

Initially, 6,376 articles were identified. After removing duplicate articles, the titles and abstracts of the articles were reviewed, and after discarding the articles unrelated to the purpose of the research and based on the inclusion criteria, the original text of 790 articles was reviewed, and then 27 articles were included in the systematic review and 24 articles in meta-analysis (Fig. 1).

The total sample size of the studies was 6,624 infertile men, with the smallest and largest sample size being 40 and 1,247 subjects, respectively. The lowest prevalence was 3.7% in Canada and the highest was 42.62% in Iran (Table 1). These studies used a variety of standard measurement tools to assess anxiety symptoms in infertile men. One study had used the Mini International Neuropsychiatric Interview (MINI), one study used the Primary Care Evaluation of Mental Disorders (PRIME-MD), one study Symptom Assessment-45 Questionnaire (SA-45), three studies used the Depression Anxiety and Stress Scale (DASS), three studies the Self-Rating Anxiety Scale (SAS), seven studies used the Hospital Anxiety and Depression Scale (HADS), six studies used the Spielberger Trait Anxiety Inventory (STAI-T), and five studies used the Beck Anxiety Inventory (BAI)

Table 1 Characteristics of the studies selected for the systematic
Full size table

Evaluation of heterogeneity and meta-analysis

The pooled prevalence of anxiety symptoms in infertile men was 21.37% (95% CI: 15.73–27.02) (Fig. 2).

Fig. 2
figure 2

Pooled prevalence of anxiety symptoms in infertile men

Full size image

The results of the funnel plot are also shown in Fig. 3. The results of Egger's regression test, with a t-value of t = 0.373 and p-value = 0.713, indicate no significant evidence of publication bias.

Fig. 3
figure 3

Funnel plot of pooled prevalence of anxiety symptoms in infertile men

Full size image

Given the fact that different tools have been used to investigate anxiety symptoms in infertile men, from the 27 articles in the systematic review section, 24 studies were used for the meta-analysis in 5 subgroups of tools (HADS, STAI-T, BAI, SAS, and DASS). The lowest and highest prevalence of anxiety in infertile men were related to the BAI and DASS tools, accounting for 7.08% (95% CI: 3.27–10.90) and 34.90% (95%CI: 28.90–40.90), respectively. This prevalence was 19.80% (95%CI: 9.01–30.59) for the HADS, 30.06% (95%CI: 18.59–41.52) for the STAI-T, and 18.52% (95%CI: 7.76–29.29) for the SAS (Table 2).

Table 2 Total and subgroup prevalence for anxiety symptoms in infertile men based on tools
Full size table

HADS

The 14-item HADS questionnaire was developed by Zigmond & Snaith (1983) to screen for symptoms of depression and anxiety in outpatient clinics of public hospitals. This questionnaire consists of 7 questions related to depression and 7 questions related to anxiety, and participants answer the questions using a 4-point Likert scale (0 to 3). The maximum possible score for each dimension is 21 [42]. Generally, scores of 0 to 7 on this questionnaire are considered to be normal, scores of 8 to 10 indicate mild symptoms, 11 to 14 indicate moderate symptoms, and 15 to 21 indicate severe symptoms [43]. The questionnaire has been translated into several languages, has psychometrically been evaluated and its validity and reliability have been confirmed [44,45,46,47].

The subgroup analysis of the HADS tool indicated that the pooled prevalence of anxiety symptoms in men was 19.80% (95% CI: 9.01–30.59) (Fig. 4).

Fig. 4
figure 4

Pooled prevalence of anxiety symptoms in infertile men of the HADS subgroup

Full size image

The results of the funnel plot are also shown in Fig. 5. The results of Egger's regression test, with a t-value of 0.130 and p-value = 0.902, suggest no significant evidence of publication bias.

Fig. 5
figure 5

Funnel plot of pooled prevalence of anxiety symptoms in infertile men of the HADS subgroup

Full size image

STAI-T

The Spielberger State-Trait Anxiety Inventory (STAI-T) is a 40-item self-report questionnaire. It is designed to assess both state anxiety (the respondent's current temporary state) and trait anxiety (the general tendency to experience anxiety). Each section of the inventory contains 20 questions, for a total of 40 items [48]. The inventory was originally developed by Spielberger, Gorsuch, and Lushene in 1970 as a tool for assessing anxiety [49]. It consists of 40 items, with response options ranging from "not at all / almost never" (1), somewhat/ sometimes (2), moderately so/ often (3), and very much so/ almost always (4). It has been widely used in numerous studies in different regions of the world and has shown good validity and reliability [50, 51].

Based on the STAI-T subgroup results, the pooled prevalence of anxiety symptoms in infertile men was 30.06% (95% CI: 18.59–41.52) (Fig. 6).

Fig. 6
figure 6

Pooled prevalence of anxiety symptoms in infertile men of the STAI-T subgroup

Full size image

The results of the funnel plot are also shown in Fig. 7. The results of Egger's regression test, with a t-value of 1.030 and p-value = 0.361, indicate no significant evidence of publication bias.

Fig. 7
figure 7

Funnel plot of the pooled prevalence of anxiety symptoms in infertile men of the STAI-T subgroup

Full size image

BAI

This questionnaire, developed by Beck et al. in 1988, consists of 21 questions related to anxiety symptoms. All questions in the questionnaire are rated on a 4-point Likert scale, with the following options: "Not at all" (0), " Slightly, but it didn't bother me much" (1), "Moderately—it was not pleasant at times" (2), and "Severely – it bothered me a lot" (3). The total score is calculated by summing up the scores of all 21 items. Scores between 0 and 21 on this questionnaire indicate low levels of anxiety, scores between 22 and 35 indicate moderate levels of anxiety, and scores of 36 and above indicate potentially higher levels of anxiety. Cronbach's alpha was reported to be 0.91 in the original version of the questionnaire and 0.75 in the open test [52]. The validity and reliability of this questionnaire have been confirmed in several studies [53,54,55].

Based on the BAI subgroup results, the pooled prevalence of anxiety symptoms in infertile men was 7.08% (95% CI: 3.27–10.90) (Fig. 8).

Fig. 8
figure 8

Pooled prevalence of anxiety symptoms in infertile men of the BAI subgroup

Full size image

The results of the funnel plot are also shown in Fig. 9. The results of Egger's regression test, with a t-value of 0.832 and p-value = 0.467, suggest no significant evidence of publication bias.

Fig. 9
figure 9

Funnel plot of pooled prevalence of anxiety symptoms in infertile men of the BAI subgroup

Full size image

SAS

The Self-Rating Anxiety Scale (SAS) [56] is a widely used tool for assessing anxiety levels in patients with anxiety-related symptoms. The SAS test follows a self-administered format in which respondents rate each item on a 4-point scale ranging from "none of the time" to "most of the time". The scale consists of 20 questions, with 15 questions assessing increasing levels of anxiety and 5 questions evaluating decreasing levels of anxiety [57]. The Cronbach's alpha coefficient for this scale has been reported to be greater than 0.80 [57,58,59], and it has demonstrated good convergent and divergent validity [57].

Based on the SAS subgroup results, the pooled prevalence of anxiety symptoms in infertile men was 18.52% (95% CI: 7.76–29.29) (Fig. 10).

Fig. 10
figure 10

Pooled prevalence of anxiety symptoms in infertile men of the SAS subgroup

Full size image

The results of the funnel plot are also shown in Fig. 11. The results of Egger's regression test, with a t-value of 2.045 and p-value = 0.290, show no significant evidence of publication bias.

Fig. 11
figure 11

Funnel plot of pooled prevalence of anxiety symptoms in infertile men of the SAS subgroup

Full size image

DASS

The Depression, Anxiety, and Stress Scale (DASS) was developed by Lovibond and Lovibond in 1995 [60]. The scale consists of 21 questions divided into three sections of Depression, Anxiety, and Stress, with each section containing 7 questions. The Likert scale used in the DASS ranges from 0 to 3, with the following response options: Did not apply to me at all—NEVER (0), applied to me to some extent, or some of the time—SOMETIMES (1), applied to me to a considerable extent, or a good part of the time—OFTEN (2), and applied to me very much, or most of the time—ALMOST ALWAYS (3). The scale is a shortened version of 42 questions of this tool, and after completing the scale, the scores are doubled to assess the situation of individuals over the past week [61]. The tool has been translated into several languages worldwide and has demonstrated validity and reliability in several studies [62,63,64].

Based on the DASS subgroup results, the pooled prevalence of anxiety symptoms in infertile men was 34.90% (95% CI: 28.90–40.90) (Fig. 12).

Fig. 12
figure 12

Pooled prevalence of anxiety symptoms in infertile men of the DASS subgroup

Full size image

The results of the funnel plot are also shown in Fig. 13. The results of Egger's regression test, with a t-value of 1.618 and p-value = 0.352, suggest no significant evidence of publication bias.

Fig. 13
figure 13

Funnel plot of pooled prevalence of anxiety symptoms in infertile men of the DASS subgroup

Full size image

Discussion

This systematic review and meta-analysis investigated the global prevalence of anxiety in infertile men. This disorder is known as the most prevalent mental disorder in the world [65]. According to the results of this study, the highest and lowest prevalence of anxiety in these men were 34.9% and 7.08%, respectively, in the studies conducted using the DASS and BAI tools, which is higher than the prevalence of anxiety in the normal population and individuals without any healthy issue [66]. In a systematic review and meta-analysis study conducted in 2023, the global prevalence of anxiety was estimated to be 4.05%. According to the results of the study, the risk of anxiety was estimated to be 2.933 per 100,000 individuals in men and 4.862 per 100,000 individuals in women worldwide [67].

The desire to have children in both men and women is influenced by several factors, including individual, cultural and religious characteristics, and failure to fulfill this desire can have potential psychological consequences for individuals, such as anxiety, stress, depression, and low self-esteem [68].

According to the results of our previous meta-analysis, the estimated prevalence of anxiety in infertile women was found to be 36%, which was higher than the prevalence of anxiety in infertile men [69]. Aligned with the results of our studies, a meta-analysis study by Almutawa et al. in 2023 indicated that the prevalence of anxiety was higher in infertile women than in infertile men [70]. Although studies have indicated that infertile women often experience higher levels of anxiety than infertile men, it is important to recognize that anxiety in infertile men is a significant issue that is often overlooked during their treatment process. In some countries, coping with infertility is psychologically more difficult for men due to cultural, social and religious reasons [11].

The inability to meet personal and societal expectations regarding male fertility and reproduction is often seen as a life crisis. This is because it challenges the traditional notion of masculinity and can be associated with social stigma and significant effects on men's quality of life [71, 72]. Furthermore, many infertile men often believe that their identity and masculinity are incomplete because of the association between fertility and male sexual prowess, which causes anxiety and psychological problems in men [12].

Several factors contribute to anxiety in infertile men, including the unknown cause of infertility, the length of the treatment process, uncertainty about treatment outcomes, complex treatments, frequent doctor visits, financial stress caused by infertility, lower levels of education, and societal pressures [18, 73]. Moreover, the way men perceive themselves in the face of infertility problems and their methods of accepting infertility are important factors influencing their level of anxiety in them [74]. Infertile men, like infertile women, often experience a loss of self-confidence and inadequacy in their social and family roles. However, they try to cope with this problem and suppress their feelings through strategies such as alienation, increased participation in daily activities, a problem-solving approach, and increased support for their spouses. This can lead to underreporting of distress levels and infertility-related mental disorders in men [36, 74].

Evidence suggests that women tend to have more social support than men [75, 76]. Men's reluctance to discuss infertility with those around them, including friends, family, and counselors, may contribute to their increased stress and anxiety, and their reluctance to seek help and support to cope with these psychological distresses further exacerbates the situation. The results of a study revealed that men may not talk much about their anxiety and other psychological distress in order to provide a strong source of support for their wives during the infertility process [66]. According to studies, the most important source of emotional support for infertile couples is the spouse, and perceived social support from the spouse and other relatives is one of the influential factors for accepting infertility and coping with stressful conditions such as infertility [76,77,78]. Based on the results of another study, it was observed that the communication and support network of infertile men tends to diminish over time [79].

Based on the results of our previous study, the prevalence of anxiety among infertile women in low-income countries was estimated to be twice as high as that in high-income countries [69]. The results of the present study also revealed that among infertile men, the lowest prevalence of anxiety was observed among Canadian participants, with a rate of 3.7%, whereas the highest prevalence of anxiety was found among Iranian infertile men, with a rate of 42.62%. Consistent with the present study, Javaid et al. [67] indicated that Iran was the third country in the world with a high prevalence of anxiety [80]. This can be due to the fact that in many developing countries, little attention is paid to the psychological well-being of patients when it comes to dealing with infertility issues [11]. Moreover, the socio-economic situation and the availability of healthcare facilities are among the factors that influence the prevalence of anxiety in infertile individuals. Given that men are the main providers of financial resources for infertility treatment, their lack of financial resources can lead to increased psychological pressure, and this psychological burden can significantly affect their quality of life, resulting in more anxiety and psychological distress in them [81]. Thus, providing universal access to and insurance coverage for infertility services is recognized as an important policy goal for many health systems and governments.

The results of several studies have demonstrated the negative impact of mental distress on parameters that predict the success of assisted reproductive methods. In 2017, Wdowiak et al. indicated in their study that anxiety and depression in infertile individuals were associated with higher prolactin and cortisol levels, lower sex hormone-binding globulin (SHBG) and dehydroepiandrosterone sulfate (DHEA-S) secretion, and lower sperm volume and quality [82]. Therefore, given the impact of mental distress on the success of assisted reproductive methods, as well as the results of Fisher and Hammarberg's study indicating that men are more likely to seek emotional support from infertility physicians than from mental health professionals, self-help groups, or friends [83], it is crucial to integrate psychological counseling into the treatment process. The treatment team should consider the diagnosis, implementation, and evaluation of anxiety reduction interventions throughout the entire treatment process.

The limitations and strengths

A limitation of this study was the exclusion of non-English language articles and the unavailability of full-text access to certain articles. The use of different tools in different studies to measure anxiety in infertile men was another limitation of the present study. However, the estimation of the prevalence of anxiety in infertile men based on different tools can be considered as one of the strengths of the present study, because it can be used as a guide to choose the appropriate tool to measure the anxiety of infertile men in cross-sectional and interventional studies.

Conclusion

The results of our study estimated the prevalence of prevalence of anxiety in infertile men 21.37% (95% CI: 15.73–27.02). Considering the prevalence of anxiety in infertile men, this issue needs attention and planning to reduce the anxiety of this group of men.

Availability of data and materials

All data related to this review is included in the result section of the manuscript. If any further data is needed it can be accessible via the corresponding author on request.

Abbreviations

WHO:

World Health Organization

NOS:

The Newcastle–Ottawa Scale

PRISMA:

Preferred Reporting Items for Systematic Reviews and Meta-Analyses

NA:

Not reported

STAI-T:

Spielberger Trait Anxiety Inventory

MINI:

Mini International Neuropsychiatric Interview

HADS:

Hospital Anxiety and Depression Scale

BAI:

Beck anxiety inventory

DASS:

Depression Anxiety Stress Scales

SAS:

The Self-Rating Anxiety Scale

PRIME-MD:

Primary Care Evaluation of Mental Disorders

SA-45:

Symptom Assessment-45 Questionnaire

SHBG:

Sex Hormone Binding Globulin

DHEA-S:

Deydroepiandrosterone-Sulfate

References

  1. Berek JS. Berek & Novak's gynecology. Lippincott Williams & Wilkins; 2019.

  2. World Health Organization (WHO). Infertility prevalence estimates: 1990–2021. 2023.

  3. Agarwal A, Baskaran S, Parekh N, Cho C-L, Henkel R, Vij S, et al. Male infertility. Lancet. 2021;397(10271):319–33.

    Article  PubMed  Google Scholar 

  4. Deshpande PS, Gupta AS. Causes and prevalence of factors causing infertility in a public health facility. J Hum Reprod Sci. 2019;12(4):287.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Massarotti C, Gentile G, Ferreccio C, Scaruffi P, Remorgida V, Anserini P. Impact of infertility and infertility treatments on quality of life and levels of anxiety and depression in women undergoing in vitro fertilization. Gynecol Endocrinol. 2019;35(6):485–9.

    Article  PubMed  Google Scholar 

  6. Kiani Z, Simbar M, Hajian S, Zayeri F. Quality of life among infertile women living in a paradox of concerns and dealing strategies: a qualitative study. Nurs Open. 2021;8(1):251–61.

    Article  PubMed  Google Scholar 

  7. Iordăchescu DA, Paica CI, Boca AE, Gică C, Panaitescu AM, Peltecu G, et al., editors. Anxiety, difficulties, and coping of infertile women. Healthcare. MDPI. 2021;15(4):466.

  8. Gamel WMA, Hassan HE, El-ezazy AA. Male infertility and psychological repercussions: α neglected problem in Northern Upper Egypt. International Journal of Studies in Nursing. 2019;4(4):1.

    Article  Google Scholar 

  9. Öztekin Ü, Hacimusalar Y, Gürel A, Karaaslan O. The relationship of male infertility with somatosensory amplification, health anxiety and depression levels. Psychiatry Investig. 2020;17(4):350.

    Article  PubMed  PubMed Central  Google Scholar 

  10. El Kissi Y, Romdhane AB, Hidar S, Bannour S, Idrissi KA, Khairi H, et al. General psychopathology, anxiety, depression and self-esteem in couples undergoing infertility treatment: a comparative study between men and women. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2013;167(2):185–9.

    Article  Google Scholar 

  11. Kooli R, Sallem A, Chebil D, Boussabbeh M, Mohamed BB, Ajina T, et al. Factors associated with anxiety and depression in men undergoing fertility investigations: a cross-sectional study. BMC psychology. 2023;11(1):299.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Fahami F, Quchani SH, Ehsanpour S, Boroujeni AZ. Lived experience of infertile men with male infertility cause. Iran J Nurs Midwifery Res. 2010;15(Suppl1):265.

    PubMed  PubMed Central  Google Scholar 

  13. Fisher J, Hammarberg K, Simoni M, Huhtaniemi I. Psychological aspects of infertility among men. In: Endocrinology of the testis and male reproduction. Cham: Springer International Publishing; 2017. p. 1287–317.

  14. Jacob JA, Aleyamma TK, Kuruvilla A, Gopalakrishnan R. Common mental disorders, quality of life and explanatory models in men undergoing infertility treatment in a tertiary care hospital: a cross-sectional study. J Psychosom Res. 2021;147:110536.

    Article  PubMed  Google Scholar 

  15. Haidich A-B. Meta-analysis in medical research. Hippokratia. 2010;14(Suppl 1):29.

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Zhang L, Fu T, Yin R, Zhang Q, Shen B. Prevalence of depression and anxiety in systemic lupus erythematosus: a systematic review and meta-analysis. BMC Psychiatry. 2017;17:1–14.

    Article  Google Scholar 

  17. Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Yang B, Zhang J, Qi Y, Wang P, Jiang R, Li H. Assessment on occurrences of depression and anxiety and associated risk factors in the infertile Chinese men. Am J Mens Health. 2017;11(3):767–74.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Vellani E, Colasante A, Mamazza L, Minasi MG, Greco E, Bevilacqua A. Association of state and trait anxiety to semen quality of in vitro fertilization patients: a controlled study. Fertility and sterility. 2013;99(6):1565–72. e2.

    Article  PubMed  Google Scholar 

  20. Schaller MA, Griesinger G, Banz-Jansen C. Women show a higher level of anxiety during IVF treatment than men and hold different concerns: a cohort study. Arch Gynecol Obstet. 2016;293:1137–45.

    Article  PubMed  Google Scholar 

  21. Zurlo MC, Cattaneo Della Volta MF, Vallone F. Re-examining the role of coping strategies in the associations between infertility-related stress dimensions and state-anxiety: implications for clinical interventions with infertile couples. Frontiers in psychology. 2020;11:614887.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Band DA, Edelmann RJ, Avery S, Brinsden PR. Correlates of psychological distress in relation to male infertility. Br J Health Psychol. 1998;3(3):245–56.

    Article  Google Scholar 

  23. Shafierizi S, Faramarzi M, Esmaelzadeh S, Khafri S, Ghofrani F. Does infertility develop posttraumatic growth or anxiety/depressive symptoms? Roles of personality traits, resilience, and social support. Perspect Psychiatr Care. 2022;58(4):2017–28.

    Article  PubMed  Google Scholar 

  24. Zhang L, Shao H, Huo M, Chen J, Tao M, Liu Z. Prevalence and associated risk factors for anxiety and depression in infertile couples of ART treatment: a cross-sectional study. BMC Psychiatry. 2022;22(1):1–9.

    Article  Google Scholar 

  25. Chen D, Zhang JP, Jiang L, Liu H, Shu L, Zhang Q, et al. Factors that influence in vitro fertilization treatment outcomes of Chinese men: a cross-sectional study. Appl Nurs Res. 2016;32:222–6.

    Article  PubMed  Google Scholar 

  26. Liu YF, Fu Z, Chen SW, He XP, Fan LY. The analysis of anxiety and depression in different stages of in vitro fertilization-embryo transfer in couples in China. Neuropsychiatr Dis Treat. 2021;25(3):649–57.

  27. Fernandes J, Pedro J, Costa ME, Martins MV. Effect of depression and anxiety on sexual functioning in couples trying to conceive with and without an infertility diagnosis. Psychol Health. 2023;38(1):58–75.

    Article  Google Scholar 

  28. Madero S, Gameiro S, García D, Cirera D, Vassena R, Rodríguez A. Quality of life, anxiety and depression of German, Italian and French couples undergoing cross-border oocyte donation in Spain. Hum Reprod. 2017;32(9):1862–70.

    Article  CAS  PubMed  Google Scholar 

  29. Maroufizadeh S, Karimi E, Vesali S, Samani RO. Anxiety and depression after failure of assisted reproductive treatment among patients experiencing infertility. Int J Gynecol Obstet. 2015;130(3):253–6.

    Article  Google Scholar 

  30. Maroufizadeh S, Ghaheri A, Almasi-Hashiani A, Mohammadi M, Navid B, Ezabadi Z, et al. The prevalence of anxiety and depression among people with infertility referring to Royan Institute in Tehran, Iran: a cross-sectional questionnaire study. Middle East fertility society journal. 2018;23(2):103–6.

    Article  Google Scholar 

  31. Anderson K, Sharpe M, Rattray A, Irvine D. Distress and concerns in couples referred to a specialist infertility clinic. J Psychosom Res. 2003;54(4):353–5.

    Article  CAS  PubMed  Google Scholar 

  32. Anh VTK, Tran QH, Van Huong T, Quyen LTN, Truong VD. Anxiety, depression and some related factors in infertile couples being treated at a provincial reproductive health care center, in the South of Vietnam. Bangladesh Journal of Medical Science. 2023;22(2):360.

    Article  Google Scholar 

  33. Musa R, Ramli R, Yazmie AWA, Khadijah MBS, Hayati MY, Midin M, et al. A preliminary study of the psychological differences in infertile couples and their relation to the coping styles. Compr Psychiatry. 2014;55:S65–9.

    Article  PubMed  Google Scholar 

  34. Samani RO, Vesali S, Navid B, Vakiliniya B, Mohammadi M. Evaluation on hope and psychological symptoms in infertile couples undergoing assisted reproduction treatment. International journal of fertility & sterility. 2017;11(2):123.

    Google Scholar 

  35. Chachamovich JL, Chachamovich E, Ezer H, Cordova FP, Fleck MM, Knauth DR, et al. Psychological distress as predictor of quality of life in men experiencing infertility: a cross-sectional survey. Reprod Health. 2010;7(1):1–9.

    Article  Google Scholar 

  36. Peterson BD, Newton CR, Feingold T. Anxiety and sexual stress in men and women undergoing infertility treatment. Fertil Steril. 2007;88(4):911–4.

    Article  PubMed  Google Scholar 

  37. Drosdzol A, Skrzypulec V. Depression and anxiety among Polish infertile couples–an evaluative prevalence study. J Psychosom Obstet Gynecol. 2009;30(1):11–20.

    Article  Google Scholar 

  38. Klemetti R, Raitanen J, Sihvo S, Saarni S, Koponen P. Infertility, mental disorders and well-being–a nationwide survey. Acta Obstet Gynecol Scand. 2010;89(5):677–82.

    Article  PubMed  Google Scholar 

  39. Alosaimi FD, Altuwirqi MH, Bukhari M, Abotalib Z, BinSaleh S. Psychiatric disorders among infertile men and women attending three infertility clinics in Riyadh, Saudi Arabia. Annals of Saudi medicine. 2015;35(5):359–67.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Volgsten H, Svanberg AS, Ekselius L, Lundkvist Ö, Poromaa IS. Risk factors for psychiatric disorders in infertile women and men undergoing in vitro fertilization treatment. Fertil Steril. 2010;93(4):1088–96.

    Article  PubMed  Google Scholar 

  41. Haimovici F, Anderson JL, Bates GW, Racowsky C, Ginsburg ES, Simovici D, et al. Stress, anxiety, and depression of both partners in infertile couples are associated with cytokine levels and adverse IVF outcome. Am J Reprod Immunol. 2018;79(4):e12832.

    Article  PubMed  Google Scholar 

  42. Edelstein BA, Drozdick LW, Ciliberti CM. Assessment of depression and bereavement in older adults. In: Handbook of assessment in clinical gerontology. Elsevier; 2010. p. 3–43.

    Chapter  Google Scholar 

  43. Singer S, Kuhnt S, Götze H, Hauss J, Hinz A, Liebmann A, et al. Hospital anxiety and depression scale cutoff scores for cancer patients in acute care. Br J Cancer. 2009;100(6):908–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. United Nations Population Fund. Strenghtening midwifery, T.m., A.P.t.M.D. health thematic fund, and G.N.Y.U.N.P.F. 2009. 2010.

  45. Johnston M, Pollard B, Hennessey P. Construct validation of the hospital anxiety and depression scale with clinical populations. J Psychosom Res. 2000;48(6):579–84.

    Article  CAS  PubMed  Google Scholar 

  46. Michopoulos I, Douzenis A, Kalkavoura C, Christodoulou C, Michalopoulou P, Kalemi G, et al. Hospital Anxiety and Depression Scale (HADS): validation in a Greek general hospital sample. Ann Gen Psychiatry. 2008;7:1–5.

    Article  Google Scholar 

  47. Bocéréan C, Dupret E. A validation study of the Hospital Anxiety and Depression Scale (HADS) in a large sample of French employees. BMC Psychiatry. 2014;14(1):1–11.

    Article  Google Scholar 

  48. Zsido AN, Teleki SA, Csokasi K, Rozsa S, Bandi SA. Development of the short version of the spielberger state—trait anxiety inventory. Psychiatry Res. 2020;291:113223.

    Article  PubMed  Google Scholar 

  49. Spielberger CD, Sydeman SJ, Owen AE, Marsh BJ. Measuring anxiety and anger with the State-Trait Anxiety Inventory (STAI) and the State-Trait Anger Expression Inventory (STAXI). Lawrence Erlbaum Associates Publishers; 1999.

  50. Azevedo FBd, Wang Y-P, Goulart AC, Lotufo PA, Benseñor IM. Application of the Spielberger’s state-trait anger expression inventory in clinical patients. Arquivos de Neuro-psiquiatria. 2010;68:231–4.

    Article  PubMed  Google Scholar 

  51. Knowles KA, Olatunji BO. Specificity of trait anxiety in anxiety and depression: meta-analysis of the State-Trait Anxiety Inventory. Clin Psychol Rev. 2020;82:101928.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56(6):893.

    Article  CAS  PubMed  Google Scholar 

  53. Toledano-Toledano F, Moral de la Rubia J, Domínguez-Guedea MT, Nabors LA, Barcelata-Eguiarte BE, Rocha-Pérez E, et al. Validity and reliability of the Beck Anxiety Inventory (BAI) for family caregivers of children with cancer. International Journal of Environmental Research and Public Health. 2020;17(21):7765.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Yochim BP, Mueller AE, June A, Segal DL. Psychometric properties of the geriatric anxiety scale: comparison to the beck anxiety inventory and geriatric anxiety inventory. Clin Gerontol. 2010;34(1):21–33.

    Article  Google Scholar 

  55. Lee K, Kim D, Cho Y. Exploratory factor analysis of the Beck anxiety inventory and the Beck depression inventory-II in a psychiatric outpatient population. Journal of Korean Medical Science. 2018;33(16):e128.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Zung WW. A rating instrument for anxiety disorders. Psychosomatics: Journal of Consultation and Liaison Psychiatry. 1971;12(6):371–9.

  57. Dunstan DA, Scott N. Norms for Zung’s self-rating anxiety scale. BMC Psychiatry. 2020;20(1):1–8.

    Article  Google Scholar 

  58. Dunstan DA, Scott N, Todd AK. Screening for anxiety and depression: reassessing the utility of the Zung scales. BMC Psychiatry. 2017;17(1):1–8.

    Article  Google Scholar 

  59. Tung VS, Thong NV, Mai NTP, Linh LTT, Son DC, Ha TTT, et al. Diagnostic value in screening severe depression of the Hamilton Depression Rating Scale, Hamilton Anxiety Rating Scale, Beck Depression Inventory Scale, and Zung’s Self-Rating Anxiety Scale among patients with recurrent depression disorder. Acta Informatica Medica. 2023;31(4):249–53.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Lovibond PF, Lovibond SH. The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behav Res Ther. 1995;33(3):335–43.

    Article  CAS  PubMed  Google Scholar 

  61. World Health Organization (WHO). https://www.who.int/teams/maternal-newborn-child-adolescent-health-and-ageing/maternal-health/midwifery. Accessed 3 Mar 2023.

  62. Yusoff MSB. Psychometric properties of the depression anxiety stress scale in a sample of medical degree applicants. International Medical Journal. 2013;20(3):295–300.

    Google Scholar 

  63. World Health Organization (WHO). Obesity and overweight. 2020. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.

  64. Musa R, Fadzil MA, Zain Z. Translation, validation and psychometric properties of Bahasa Malaysia version of the Depression Anxiety and Stress Scales (DASS). Asean Journal of Psychiatry. 2007;8(2):82–9.

    Google Scholar 

  65. Steel Z, Marnane C, Iranpour C, Chey T, Jackson JW, Patel V, et al. The global prevalence of common mental disorders: a systematic review and meta-analysis 1980–2013. Int J Epidemiol. 2014;43(2):476–93.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Biggs SN, Halliday J, Hammarberg K. Psychological consequences of a diagnosis of infertility in men: a systematic analysis. Asian J Androl. 2024;26(1):10–9.

    Article  PubMed  Google Scholar 

  67. Javaid SF, Hashim IJ, Hashim MJ, Stip E, Samad MA, Ahbabi AA. Epidemiology of anxiety disorders: global burden and sociodemographic associations. Middle East Current Psychiatry. 2023;30(1):44.

    Article  Google Scholar 

  68. Wichman CL, Ehlers SL, Wichman SE, Weaver AL, Coddington C. Comparison of multiple psychological distress measures between men and women preparing for in vitro fertilization. Fertil Steril. 2011;95(2):717–21.

    Article  PubMed  Google Scholar 

  69. Kiani Z, Simbar M, Hajian S, Zayeri F, Shahidi M, Saei Ghare Naz M, et al. The prevalence of anxiety symptoms in infertile women: a systematic review and meta-analysis. Fertility Research and Practice. 2020;6:1–10.

    Article  Google Scholar 

  70. Almutawa YM, AlGhareeb M, Daraj LR, Karaidi N, Jahrami H, Karaidi NA. A Systematic review and meta-analysis of the psychiatric morbidities and quality of life differences between men and women in infertile couples. Cureus. 2023;15(4):1–17.

  71. Hanna E, Gough B. Experiencing male infertility: a review of the qualitative research literature. SAGE Open. 2015;5(4):2158244015610319.

    Article  Google Scholar 

  72. Szatmári A, Helembai K, Zádori J, Kovács I. Paramedical counselling in infertility treatment: its effects on anxio-depressive symptom severity, perceived stress and self-esteem. Heliyon. 2022;8(7):e09827.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Abdishahshahani M, Torabi M, Kazemi A. Investigating related factors to psychological symptoms of infertile couples undergoing assisted reproductive treatment. J Educ Health Promot. 2020;9(4):5–9.

  74. Glover L, Abel P, Gannon K. Male subfertility: is pregnancy the only issue?: Psychological responses matter too—and are different in men. BMJ. 1998;316:1405–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Nagórska M, Bartosiewicz A, Obrzut B, Darmochwał-Kolarz D. Gender differences in the experience of infertility concerning polish couples: preliminary research. Int J Environ Res Public Health. 2019;16(13):2337.

    Article  PubMed  PubMed Central  Google Scholar 

  76. Jafarzadeh-Kenarsari F, Ghahiri A, Habibi M, Zargham-Boroujeni A. Exploration of infertile couples’ support requirements: a qualitative study. International journal of fertility & sterility. 2015;9(1):81.

    CAS  Google Scholar 

  77. Hegyi BE, Kozinszky Z, Badó A, Dombi E, Németh G, Pásztor N. Anxiety and depression symptoms in infertile men during their first infertility evaluation visit. J Psychosom Obstet Gynecol. 2019;40(4):311–7.

    Article  Google Scholar 

  78. Hammarberg K, Baker H, Fisher J. Men’s experiences of infertility and infertility treatment 5 years after diagnosis of male factor infertility: a retrospective cohort study. Hum Reprod. 2010;25(11):2815–20.

    Article  CAS  PubMed  Google Scholar 

  79. Peronace LA, Boivin J, Schmidt L. Patterns of suffering and social interactions in infertile men: 12 months after unsuccessful treatment. J Psychosom Obstet Gynecol. 2007;28(2):105–14.

    Article  Google Scholar 

  80. CDC. 2019. https://wonder.cdc.gov/wonder/prevguid/tp_00828.html. https://www.cdc.gov/features/perinatal-screening/index.html.

  81. Dooley M, Nolan A, Sarma K. The psychological impact of male factor infertility and fertility treatment on men: a qualitative study. The Irish Journal of Psychology. 2011;32(1–2):14–24.

    Article  Google Scholar 

  82. Wdowiak A, Bien A, Iwanowicz-Palus G, Makara-Studzińska M, Bojar I. Impact of emotional disorders on semen quality in men treated for infertility. Neuro-endocrinology Letters. 2017;38(1):50.

    CAS  PubMed  Google Scholar 

  83. Fisher JR, Hammarberg K. Psychological and social aspects of infertility in men: an overview of the evidence and implications for psychologically informed clinical care and future research. Asian journal of andrology. 2012;14(1):121.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors would like to express their gratitude and appreciation for the cooperation and assistance of the officials of the faculty, library and computer department of Shahid Beheshti University of Medical Sciences.

Funding

The authors declare that no funding, grants, or other support was received during the preparation of this manuscript.

Author information

Authors and Affiliations

  1. Midwifery and Reproductive Health Research Center, Department of Midwifery and Reproductive Health, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Masoumeh Simbar

  2. Department of Public Health, Asadabad School of Medical Sciences, Asadabad, Iran

    Vida Ghasemi

  3. Department of Biostatistics, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Reza Taherian

  4. Department of Midwifery and Reproductive Health, Midwifery and Reproductive Health Research Center, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Mehri Kalhor

  5. Department of Midwifery and Reproductive Health, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Fateme Mohammadian

  6. Midwifery and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Zahra Kiani

Authors
  1. Masoumeh Simbar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vida Ghasemi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Reza Taherian
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mehri Kalhor
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Fateme Mohammadian
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Zahra Kiani
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

MS: Project administration, writing-review, and editing, supervision. VG: Project administration, writing-review, and editing, supervision. RT: Project development, Data Analysis, Manuscript writing/ MK: Data Collection, Manuscript writing. FM: Data Collection, Manuscript writing. ZK: Project development, Data Collection, Manuscript writing, Data Analysis. All authors have read and approved the final manuscript.

Corresponding author

Correspondence to Zahra Kiani.

Ethics declarations

Ethics approval and consent to participate

Ethics approval was obtained from the Ethics Committee, Faculty of Pharmacy, Nursing And Midwifery, Shahid Beheshti University (Ethical code: IR.SBMU.RETECH.REC.1402.497). All methods were performed in accordance with relevant guidelines and regulations.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Simbar, M., Ghasemi, V., Taherian, R. et al. Prevalence of anxiety symptoms in infertile men: a systematic review and meta-analysis. BMC Public Health 24, 1805 (2024). https://doi.org/10.1186/s12889-024-19299-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12889-024-19299-8

Keywords

BMC Public Health

ISSN: 1471-2458

Contact us